Author

Joo Young Song

City Of Hope National Medical CenterORCID 0000-0003-3497-2513Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Organism:human· 3 Approach:statistical model· 3 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Research Focus:gene regulatory network inference· 2 Research Focus:cell-cell communication· 1 Research Focus:chromatin & epigenetic regulation· 1

Frequent Co-Authors

Adrian AndronacheiD· 1 shared Alan B CooperiD· 1 shared Alessandra TucciiD· 1 shared Alexander BagaeviD· 1 shared Amy LeungiD· 1 shared Andrés J.M. FerreriiD· 1 shared Anojan SivacegaramiD· 1 shared Antonello Domenico CabrasiD· 1 shared

Activity by Year

2025-2025 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adrian AndronacheORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintJul 22, 2025

Methylation variability and LINE-1 activation in multiple myeloma

Qianhui Wan, Amy Leung, Mahek Vinod Bhandari…·Dustin E. Schones

The paper identifies heterogeneous DNA methylation loss and LINE-1 activation in multiple myeloma, linking them to KZFP expression reduction and disease progression.

DOI 10.1101/2025.07.22.666173

humanDNA methylation

𝕏 PostBluesky

Cancer BiologyBlood Cancer DiscoveryPeer-reviewedMay 22, 2025

B cell receptor silencing reveals the origin of high-grade B cell lymphomas with MYC and BCL2 rearrangements

Gabriele Varano, Silvia Lonardi, Paola Sindaco…·Stefano S Casola

This paper shows that high-grade B cell lymphomas with MYC and BCL2 rearrangements originate from BCR-silenced follicular lymphoma cells that acquire IGL::MYC translocations, leading to resistance to CD79B-targeting therapy.

10 citationstop 2%

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologyBloodPeer-reviewedJan 27, 2025

Integrative genomic analysis identifies unique immune environments associated with immunotherapy response in diffuse large B cell lymphoma

Sravya Tumuluru, James K. Godfrey, Alan B Cooper…·Justin Paul Kline

This study identifies unique immune environments in DLBCL associated with response to immunotherapy using an integrative multi-omic approach.

35 citationstop 1%

humanbulk RNA-seq

𝕏 PostBluesky